1. Insights into the role of STAT3 in intrahepatic cholangiocarcinoma (Review)
    Ranzhiqiang Yang et al, 2022, Molecular Medicine Reports CrossRef
  2. Silencing of type Iγ phosphatidylinositol phosphate kinase suppresses ovarian cancer cell proliferation, migration and invasion
    Siyu Cao et al, 2017, Oncology Reports CrossRef
  3. Oligonucleotide-Based Therapeutics for STAT3 Targeting in Cancer—Drug Carriers Matter
    Sara Molenda et al, 2023, Cancers CrossRef
  4. Transcription factor decoy: a pre-transcriptional approach for gene downregulation purpose in cancer
    Seyed Mohammad Ali Hosseini Rad et al, 2015, Tumor Biology CrossRef
  5. Targeting STAT3 in cancer and autoimmune diseases
    Tohid Gharibi et al, 2020, European Journal of Pharmacology CrossRef
  6. Targeting transcription factor STAT3 for cancer prevention and therapy
    Edna Zhi Pei Chai et al, 2016, Pharmacology & Therapeutics CrossRef
  7. Antrodia camphorata Mycelia Exert Anti-liver Cancer Effects and Inhibit STAT3 Signaling in vitro and in vivo
    Pei-Li Zhu et al, 2018, Frontiers in Pharmacology CrossRef
  8. Novel Nanocomplexes Targeting STAT3 Demonstrate Promising Anti-Ovarian Cancer Effects in vivo


    Xiaolei Zhang et al, 2020, OncoTargets and Therapy CrossRef
  9. STAT3 Decoy Oligodeoxynucleotides-Loaded Solid Lipid Nanoparticles Induce Cell Death and Inhibit Invasion in Ovarian Cancer Cells
    Yanhui Ma et al, 2015, PLOS ONE CrossRef
  10. Targeting feedback activation of signaling transduction pathways to overcome drug resistance in cancer
    Xuejian Wang et al, 2022, Drug Resistance Updates CrossRef
  11. Proteomic identification of the oncoprotein STAT3 as a target of a novel Skp1 inhibitor
    Xin Cheng et al, 2017, Oncotarget CrossRef
  12. Restoring TRAIL Mediated Signaling in Ovarian Cancer Cells
    Ammad Ahmad Farooqi et al, 2014, Archivum Immunologiae et Therapiae Experimentalis CrossRef
  13. STAT3 Inhibitors in Cancer: A Comprehensive Update
    Uddalak Bharadwaj et al, 2016, STAT Inhibitors in Cancer CrossRef
  14. Targeting Janus Kinases and Signal Transducer and Activator of Transcription 3 to Treat Inflammation, Fibrosis, and Cancer: Rationale, Progress, and Caution
    Uddalak Bharadwaj et al, 2020, Pharmacological Reviews CrossRef
  15. Targeting the IL-6/JAK/STAT3 signalling axis in cancer
    Daniel E. Johnson et al, 2018, Nature Reviews Clinical Oncology CrossRef
  16. Thymoquinone induces apoptosis in human colon cancer HCT116 cells through inactivation of STAT3 by blocking JAK2- and Src-mediated phosphorylation of EGF receptor tyrosine kinase
    JUTHIKA KUNDU et al, 2014, Oncology Reports CrossRef
  17. STAT3β Enhances Sensitivity to Concurrent Chemoradiotherapy by Inducing Cellular Necroptosis in Esophageal Squamous Cell Carcinoma
    Zhen-Yuan Zheng et al, 2021, Cancers CrossRef
  18. Targeting STAT3 in Cancer with Nucleotide Therapeutics
    Yue-Ting K. Lau et al, 2019, Cancers CrossRef
  19. Role of Oct4–Sox2 complex decoy oligodeoxynucleotides strategy on reverse epithelial to mesenchymal transition (EMT) induction in HT29-ShE encompassing enriched cancer stem-like cells
    Zahra Bigdelou et al, 2020, Molecular Biology Reports CrossRef
  20. miR-215 functions as a tumor suppressor in epithelial ovarian cancer through regulation of the X-chromosome-linked inhibitor of apoptosis
    GUANQUN GE et al, 2016, Oncology Reports CrossRef
  21. miR-146a Inhibits Proliferation and Enhances Chemosensitivity in Epithelial Ovarian Cancer via Reduction of SOD2
    YaJie Cui et al, 2016, Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics CrossRef
  22. STAT3 as a Major Contributor to Chemoresistance
    David S. Lee et al, 2019, Targeting Cell Survival Pathways to Enhance Response to Chemotherapy CrossRef
  23. Label-free detection of cancer related gene based on target recycling and palindrome-mediated strand displacement amplification
    Huo Xu et al, 2020, Talanta CrossRef
  24. Exploring Novel Frontiers: Leveraging STAT3 Signaling for Advanced Cancer Therapeutics
    Taiwo Adesoye et al, 2024, Cancers CrossRef